• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Boosting the Immune System to Treat Diabetic Retinopathy.

Grant number: 1-PDF-2020-969-A-N | Funding period: 2020 - 2021

Completed

Related publications (3)

Scholarly works icon

Targeting RORγ to Boost Regulatory T cells and Ameliorate Diabetic Retinopathy in Mice

D Deliyanti, V Suphapimol, P Ang, A Jayasimhan, JL Wilkinson-Berka

2026-02-01

Diabetic retinopathy, a leading cause of blindness, features damage to the retinal vasculature, where T-cell–mediated inflammation..

Scholarly works icon

Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3 Tregs and CD8 T cells

D Deliyanti, V Suphapimol, A Joglekar, A Jayasimhan, JL Wilkinson-Berka

2025-07-01

Aims/hypothesis: Diabetic retinopathy features damage to the retinal microvasculature that causes vessels to leak and proliferate ..

Scholarly works icon

Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination

Jae Young Lee, Min Joung Kim, Devy Deliyanti, Michael F Azari, Fernando Rossello, Adam Costin, Georg Ramm, Edouard G Stanley, Andrew G Elefanty, Jennifer L Wilkinson-Berka, Steven Petratos

2017-11-01

Cell membrane thyroid hormone (TH) transport can be facilitated by the monocarboxylate transporter 8 (MCT8), encoded by the solute..

University of Melbourne Researchers

Devy Deliyanti's Profile Picture
Devy Deliyanti

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224